Clinical Trials Logo
  1. Home
  2. Cognitive Impairment
  3. NCT03104088
  4. Details
NCT03104088 Clinical Trial

Studying Cognition in SPG4

Cognitive Impairment Clinical Trial

Official title:
Studying Cognition in SPG4 Compared to Healthy Controls

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03104088
Other study ID # Cognition_SPG4
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 10, 2017
Est. completion date December 24, 2017

Study information
Verified date August 2020
Source University Hospital Tuebingen
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Comparing the cognitive levels of patients with SPG4 mutations to healthy controls.

Description:

Comparing the cognitive levels of patients with SPG4 mutations to healthy controls by using the CANTAB® and MoCA.

Recruitment information / eligibility
Status Completed
Enrollment 50
Est. completion date December 24, 2017
Est. primary completion date December 24, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Patient with SPG4 with known SPAST-Mutation (patient group) or healthy control

- Age 18 to 70 years

- Written, informed consent

Exclusion Criteria:

- Lack of ability for a written, informed consent

- Presence of gait disorder or other neurological condition (for healthy controls)

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• CANTAB
CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG)
• MOCA
Montreal cognitive assessment (MOCA) in German

Locations
Country Name City State
Germany University Hospital Tübingen, Center for Neurology Tubingen

Sponsors (1)
Lead Sponsor Collaborator
University Hospital Tuebingen

Country where clinical trial is conducted

Germany, 

References & Publications (1)

Rattay TW, Boldt A, Völker M, Wiethoff S, Hengel H, Schüle R, Schöls L. Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4). J Neurol. 2020 Feb;267(2):369-379. doi: 10.1007/s00415-019-09573-w. Epub 2019 Oc — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Identifying cognitive affected domains by using CANTAB Number of SPG4 patients with affections in the examined cognitive domains by using CANTAB day 1
See also
  Status Clinical Trial Phase
Completed NCT02122198 - Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women N/A
Recruiting NCT04356924 - Psychological Treatment to Support the Consequences of Cognitive Impairment N/A
Suspended NCT05542238 - The Effect of Acute Exercise on Cardiac Autonomic, Cerebrovascular, and Cognitive Function in Spinal Cord Injury N/A
Terminated NCT04493957 - Evaluation of an Educational Program in the Prevention of the Driving Risks in Patients With Neurocognitive Disorders : ACCOMPAGNE N/A
Recruiting NCT04792983 - Cognition and the Immunology of Postoperative Outcomes
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Not yet recruiting NCT05068323 - Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients N/A
Completed NCT04426838 - Cognitive Behavioral Therapy for Insomnia for the Dementia Caregiving Dyad N/A
Completed NCT04713384 - Remote Bimanual Virtual Rehabilitation Post CVD N/A
Recruiting NCT06284213 - Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Recruiting NCT06053775 - Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP) N/A
Completed NCT03698695 - A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers Phase 1
Not yet recruiting NCT05552729 - Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors Phase 1/Phase 2
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT03187353 - IMProving Executive Function Study Phase 4
Completed NCT03301402 - Air Purifier to Improve Endothelial Function and Carotid Intima Thickness N/A
Completed NCT05395559 - Prevalence and Recognition of Cognitive Impairment in Hospitalized Patients: a Flash Mob Study
Recruiting NCT04907565 - Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Recruiting NCT05030285 - Telehealth Psychotherapy for Anxiety in Persons With Cognitive Impairment N/A

External Links